The IHRC is seeking an ISO/IEC 17025 accredited laboratory that employs validated state-of-the-art methodology to detect drugs and their metabolites in test samples. Proposals should also include any other applicable certifications or accreditations including but not limited to certification by the Racing Medication and Testing Consortium (“RMTC”). Every equine biological sample provided shall be tested to detect any and all drug substances that are foreign to the natural horse, as well as endogenous substances in excess of normal levels. Every equine biological sample provided shall meet Thoroughbred Owners and Breeders Association (“TOBA”) Graded Stakes Drug Testing Protocol and the ARCI/RMTC promulgated thresholds. The vendor shall monitor the regulated medication programs adopted by the IHRC, by testing the equine biological samples as specified in the RFP. Testing must be accurate, and results must be reported in an expedient manner. A laboratory with experience in equine biological sample testing is needed to perform these services.
